Abstract
Infections have been implicated in around 18% of all malignancy in humans. The common infections include viruses, bacteria and Schistosomes. The role of bacteria in carcinogenesis is now quite evident particularly in H. pylori induced gastric cancer and mucosa associated lymphnoid tissue (MALT) lymphoma and Salmonella typhi causing carcinoma gallbladder. The chronic inflammation is the important mechanism involved in the majority of bacteria induced malignancies. The chronic inflammation is mediated by various pro and anti – inflammatory cytokines including IL-1, IL-6, IL-17, TNF-α and IL-10. The key factor in the inflammatory process is the activation of NF-kB. Various toxins are produced by different bacteria which cause direct damage to the host cells by DNA damage or affecting DNA repair mechanism resulting in alteration in the enzyme transcription or translation. It has also been postulated that bacterial infection activate inflammatory/immune cells to generate reactive oxygen species (ROS) and reactive nitrogen species (RNS) which causes DNA damage leading to cancer. The free radicals generated also acts at different levels which affects the cellular homeostasis.
The epigenetic alteration in form of DNA methylation and histone modification has also been reported in bacteria induced carcinogenesis. The other alternative molecules has been evolved by the bacteria that involved in adhesions of bacteria to cell surfaces, modulation of cytoskeleton or junctional activities and affecting specific signaling pathways.
The studies have shown that bacterial infection also causes immune modulation and result in persistence of the infection. It is also seen that not only the bacterial pathogen but the host genetic factors also determine the susceptibility and persistence of infection. The certain genotypes of inflammatory mediators are associated with increased risk of cancer. Thus, the bacteria induced carcinogenesis is a multifaceted, complex process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 4HNE:
-
4-hydroxynonenal
- AP-1:
-
Activator Protein-1
- BMP:
-
Bone Morphogenetic Protein
- Cag A:
-
Cytotoxin Associated Gene Antigen
- Cag PAI:
-
Cag A pathogenicity Associated Island
- CDT:
-
Cytolethal Distending Toxin
- Cif:
-
Cycle Inhibiting Factor
- CNF:
-
Cytotoxic Necrotizing Factor
- COX-2:
-
Cyclooxygenase-2
- CpG:
-
—C—phosphate—G—
- dG:
-
deoxyguanosine
- EDIN:
-
Epidermal Differentiation Inhibiting Factor
- ERK:
-
Extracellular Regulated Tyrosine Kinase
- FAK:
-
Focal Adhesion Kinase
- H. pylori :
-
Helicobacter pylori
- HAT:
-
Histone Acetyl Transferases
- HDACs:
-
Histone Deacetylase
- HlpA:
-
Histone Like Protein
- ICAM-1:
-
Intercellular Cell Adhesion Molecules
- IKK:
-
Inhibitory Kappa B Kinase
- IL:
-
Interleukin
- INF:
-
Interferon
- iNOS:
-
inducible Nitric Oxide Synthase
- Kb:
-
Kilobase
- KDa:
-
Kilo Dalton
- LPS:
-
Lipopolysaccharide
- LTA:
-
Lipoteichoic acid
- MALT:
-
Mucosa Associated Lymphoid Tissue
- MAPK:
-
Mitogen Activated Protein Kinase
- MIP:
-
Macrophage inflammatory protein
- NF-κB:
-
Nuclear Factor Kappa B
- NG:
-
Nitroguanine
- PMT:
-
Pasturella multocida toxin
- RN:
-
Recepter Antgonist
- RNS:
-
Reactive Nitrogen Species
- ROS:
-
Reactive Oxygen Species
- RR:
-
Relative Risk
- Shh:
-
Sonic Hedgehog Homolog
- SRF:
-
Serum Response Factor
- T4SS:
-
Type IV Secretion Apparatus
- TH1:
-
Type 1Helper T-cell
- TLR4:
-
Toll like Receptor 4
- TNF:
-
Tumour Necrosis factor
- VacA:
-
Vacuolating Cytotoxin
- VEGF:
-
Vascular Endothelial Growth Factor
References
Alberg AJ, Brock MV, Samet JM (2005) Epidemiology of lung cancer: looking to the future. J Clin Oncol 23(14):3175–3185
Axelrod L, Munster AM, O’Brien TF (1971) Typhoid cholecystitis and gallbladder carcinoma after interval of 67 years. JAMA 217(1):83
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Bartsch H, Nair J (2005) Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutat Res 591:34–44
Bayliss R, Clarke C, Oakeley CM et al (1983) The microbiology and pathogenesis of infective endocarditis. Br Heart J 50(6):513–519
Bereswill S, Waidner U, Odenbreit S et al (1998) Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology 144:2505–2516
Bereswill S, Greiner S, van Vliet AHM et al (2000) Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J Bacteriol 182(21):5948–5953
Biarc J, Nguyen IS, Pini A et al (2004) Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 25(8):1477–1484
Bisno AL (1991) Streptococcal infection. In: Harrison TR, Wilson JD, Isselbacher KJ et al (eds) Harrison’s principles of internal medicine, 12th edn. McGraw-Hill, New York, pp 563–569
Blaser MJ, Atherton JC (2004) Helicobacter pylori persistence: biology and disease. J Clin Invest 113(3):321–333
Burns CA, McCaughey R, Lauter CB (1985) The association of Streptococcus bovis fecal carriage and colon neoplasia; possible relationship with polyps and their premalignant potential. Am J Gastroenterol 80(1):42–44
Calam J (1999) Helicobacter pylori modulation of gastric acid. Yale J Biol Med 72:195–202
Caygill CP, Hill MJ, Braddick M et al (1994) Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet 343(8889):83–84
Chaturvedi AK, Gaydos CA, Agreda P et al (2010) Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 19(6):1498–1505
Chen LT, Lin JT, Tai JJ et al (2005) Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst 97(18):1345–1353
Covacci A, Censini S, Bugnoli M et al (1993) Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 90(12):5791–5795
Cutait R, Mansur A, Habr-Gama A (1988) Endocardite por streptococcus bovis e polipos de colon. Rev Bras Coloproctol 8:109–110
de Jong R, Altare F, Haagen IA et al (1998) Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science 280(5368):1435–1438
de Martel C, Franceschi S (2009) Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol 70(3):183–194
Ellmerich S, Scholler M, Duranton B et al (2000) Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21(4):753–756
El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398–402
El-Omar EM, Rabkin CS, Gammon MD et al (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124(5):1193–1201
Fan T, Lu H, Hu H et al (1998) Inhibition of apoptosis in Chlamydia- infected cells: blockade of mitochondrial cytochrome C release and caspase activation. J Exp Med 187(4):487–496
Ferlay J, Bray F, Pisani P et al (2004) GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, IARC CancerBase No.5, version 2.0. IARC Press, Lyon
Fiorentini C, Matarrese P, Straface E et al (1998) Toxin-induced activation of Rho GTP-binding protein increases Bcl-2 expression and influences mitochondrial homeostasis. Exp Cell Res 242(1):341–350
Fox J, Wang TC, Parsonnet J (2006) Helicobacter, chronic infection and cancer. In: Zur Hausen H (ed) Infectious causes of human cancer. Wiley- VCH, Weinheim, pp 386–466
Friedrich IA, Wormser GP, Gottfried EB (1982) The association of remote Streptococcus bovis bacteremia with colonic neoplasia. Am J Gastroenterol 77(2):82–84
Gaydos CA (2000) Growth in vascular cells and cytokine production by Chlamydia pneumoniae. J Infect Dis 181(Suppl 3):S473–S478
Geng Y, Shane RB, Berencsi K et al (2000) Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10. J Immunol 164(10):5522–5529
Gold JS, Bayar S, Salem RR (2004) Association of Streptcoccus bovis bacteremia with colonic neoplasia and extra-colonic malignancy. Arch Surg 139(7):760–765
Grinberg M, Mansur AJ, Ferreira DO et al (1990) Endocardite Por Streptococcus bovis e neoplasias de colon e reto. Arq Bras Cardiol 54(4):265–269
Häcker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 357:re13
Haghjoo E, Galán JE (2004) Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci USA 101(13):4614–4619
Hahn DL, Azenabor AA, Beatty WL et al (2002) Chlamydia pneumoniae as a respiratory pathogen. Front Biosci 7:66–76
Harris PR, Smythies LE, Smith PD et al (2000) Inflammatory cytokines mRNA expression during early and persistent Helicobacter pylori infection in nonhuman primates. J Infect Dis 181(2):783–786
Helicobacter and Cancer Collaborative Group (2001) Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 49(3):347–353
Hoen B, Briancon S, Delahaye F et al (1994) Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case-control study. Clin Infect Dis 19(2):361–362
Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121(11):2373–2380
International Agency for Research on Cancer (1994) IARC monographs on the evaluation of carcinogenic risks to humans, vol 61, Schistosomes, liver flukes and Helicobacter pylori. International Agency for Research on Cancer, Lyon
Karin M, Greten FR (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759
Keates S, Keates AC, Warny M et al (1999) Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag + and cag − Helicobacter pylori. J Immunol 163(10):5552–5559
Kempf AJ, Volkmann B, Schaller M et al (2001) Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol 3(9):623–632
Keusch GT (1974) Opportunistic infection in colon carcinoma. Am J Clin Nutr 27(12):1481–1485
Knudtson LM, Hartman PA (1993) Comparison of fluorescent gentamicin thallous- carbonate and KF streptococcal agars to enumerate enterococci and fecal streptococci in meats. Appl Environ Microbiol 59(3):936–938
Kocazeybeck B (2003) Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 52:721–726
Koyi H, Branden E, Gnarpe J et al (1999) Chlamydia pneumonia may be associated with lung cancer. Preliminary report on a seroepidemiological study. APMIS 107(9):828–832
Kundu JK, Surh YJ (2008) Inflammation: gearing the journey to cancer. Mutat Res 659(1–2):15–30
Kusters JG, van Vliet AHM, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori Infection. Clin Microbiol Rev 19(3):449–490
Lax AJ, Grigoriadis AE (2001) Pasteurella multocida toxin: the mitogenic toxin that stimulates signalling cascades to regulate growth and differentiation. Int J Med Microbiol 291(4):261–268
Lax AJ, Thomas W (2002) How bacteria could cause cancer: one step at a time. Trends Microbiol 10(6):293–299
Lee WP, Tai DI, Lan KH et al (2005) The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res 11(18):6431–6441
Leport C, Bure A, Leport J et al (1987) Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1(8535):8748
Litman AJ, White E, Jackson LA et al (2004) Chlamydia pneumonia infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 13(10):1624–1630
Litman AJ, Jackson LA, Vaughan TL (2005) Chlamydia pneumoniae and lung cancer. Epidemiologic Evidence 14(4):773–778
Mager DL (2006) Bacteria and cancer: cause, coincidence or cure? a review. J Transl Med 4:14
Marches O, Ledger TN, Boury M et al (2003) Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition. Mol Microbiol 50(5):1553–1567
McCoy WC, Mason JM (1951) Enterococcal endocarditis associated with carcinoma of the sigmoid: report of a case. J Med Assoc State Ala 21(6):162–166
McNamara D, El-Omar E (2008) Helicobacter pylori infection and the pathogenesis of gastric cancer: A paradigm for host–bacterial interactions. Dig Liver Dis 40:504–509
Mitsuno Y, Yoshida H, Maeda S et al (2001) Helicobacter pylori induces transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells. Gut 49(1):18–22
Murray HW, Roberts RB (1978) Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med 138(7):1097–1099
Nath G, Singh YK, Kumar K et al (2008) Association of carcinoma of the gallbladder with typhoid carriage in a typhoid endemic area using nested PCR. J Infect Dev Ctries 2(4):302–307
Nath G, Gulati AK, Shukla VK (2010) Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol 16(43):5395–5404
Nougayrède JP, Taieb F, De Rycke J et al (2005) Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol 13(3):103–110
Ohshima H, Sawa T, Akaike T (2006) 8-Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal 8:1033–1045
Parsonnet J, Hansen S, Rodriguez L et al (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330(18):1267–1271
Pasare C, Medzhitov R (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 6(15):1382–1387
Pisani P, Parkin DM, Munoz N et al (1997) Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6(6):387–400
Ruoff KL, Miller SI, Garner CV et al (1989) Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J Clin Microbiol 27(2):305–308
Saccani S, Pantano S, Natoli G (2002) p38-Dependent marking of inflammatory genes for increased NF-kB recruitment. Nat Immunol 3(1):69–75
Schlegel L, Grimont F, Ageron E et al (2003) Reappraisal of the taxonomy of the Streptococcus bovis/Streptococcus equinus complex related species: description of Streptococcus gallolyticus subsp. gallolyticus subsp. nov., S. gallolyticus subsp. macedonius subsp. nov. and Streptococcus gallolyticus subsp. Pasteurianus subsp.nov. Int J Syst Evol Microbiol 53:631–645
Shenker BJ, McKay T, Datar S (1999) Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 162(8):4773–4780
Shukla VK, Singh H, Pandey M et al (2000) Carcinoma of the gallbladder-is it a sequel of typhoid? Dig Dis Sci 45(5):900–903
Sipponen P, Kekki M, Haapakoski J et al (1985) Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 35(2):173–177
Stinson MW, McLaughlin R, Choi SH et al (1998) Streptococcal histone-like protein: primary structure of hlpA and protein binding to lipoteichoic acid and epithelial cells. Infect Immun 66(1):259–265
Suerbaum S, Michetti P (2002) Helicobacter pylori infection. N Engl J Med 347(15):1175–1186
Sugai M, Hashimoto K, Kikuchi A et al (1992) Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem 267(4):2600–2604
Suzuki H, Minegishi Y, Nomoto Y et al (2005) Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils. J Pathol 206(2):186–197
Teitz S, Guidetti-Sharon A, Manor H et al (1995) Pyogenic liver absence: warning indication of silent colonic cancer. Report of a case and review of the literature. Dis Colon Rectum 38(11):1220–1223
Thomas W, Pullinger GD, Lax AJ et al (2001) Escherichia coli cytotoxic necrotizing factor and Pasteurella multocida toxin induce focal adhesion kinase autophosphorylation and Src association. Infect Immun 69(9):5931–5935
Tjalsma H, Guinard MS, Lasonder E et al (2006) Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int J Cancer 119(9):2127–2135
Vogelmann R, Amieva MR (2007) The role of bacterial pathogens in cancer. Curr Opin Microbiol 10(1):76–81
Waisberg J, de O Matheus C, Pimenta J (2002) Infectious endocarditis from Streptococcus bovis associated with colonic carcinoma: case report and literature review. Arq Gastroenterol 39(3):177–180
Welton JC, Marr JS, Friedman SM (1979) Association between hepatobiliary cancer and typhoid carrier state. Lancet 1(8120):791–794
Wendum D, Masliah J, Trugnan G et al (2004) Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch 445(4):327–333
Yagyu K, Kikuchi S, Obata Y (2008) Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan. Int J Cancer 122(4):924–929
Yamamoto Y, Verma UN, Prajapati S et al (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423(6940):655–659
Yermilov V, Rubio J, Becchi M et al (1995) Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. Carcinogenesis 16(9):2045–2050
Zur Hausen H (2006) Streptococcus bovis: casual or incidental involvement in cancer of the colon? Int J Cancer 119(9):xi–xii
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Puneet, Nath, G., Shukla, V.K. (2012). Possible Strategies of Bacterial Involvement in Cancer Development. In: Khan, A. (eds) Bacteria and Cancer. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2585-0_7
Download citation
DOI: https://doi.org/10.1007/978-94-007-2585-0_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-2584-3
Online ISBN: 978-94-007-2585-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)